John Kastelein

Operates as a medical center and provides scientific research & education services for next generation of healthcare professionals

Functions as a College/University

Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor.

The Familial Hypercholesterolemia Foundation focuses on the inherited condition known as familial hypercholesterolemia (FH), which causes high levels of low-density lipoprotein cholesterol (LDL-C) at an early age. The non-profit company is based in Pasadena, CA. FH is estimated to affect 1 million people in the United States, but less than 10% are diagnosed. Heterozygous FH (HeFH) is the more common type and occurs in approximately 1 in 250 people, with a 50% chance of passing the condition to their offspring.

Develops novel therapies

Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases

Engages in research and development of transformative therapies for cardio metabolic diseases

Manufactures medicines for the treatment of inflammatory and cardiovascular diseases